GDNF treatment in Parkinson's disease: time for controlled clinical trials?
Brundin
Patrik
P
D000818:Animals; D018849:Controlled Clinical Trials as Topic / Q000379:methods*; D051100:Glial Cell Line-Derived Neurotrophic Factor; D006801:Humans; D009414:Nerve Growth Factors; D009419:Nerve Tissue Proteins / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000188:drug therapy*
C495039:GDNF protein, human; D051100:Glial Cell Line-Derived Neurotrophic Factor; D009414:Nerve Growth Factors; D009419:Nerve Tissue Proteins